日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models

时间序列聚类捕捉到早期免疫效应细胞相关血液毒性的模式,这些模式可使用基于树的模型进行预测。

Liang, Emily C; Jeon, Yein; Qiao, Yang; Wu, Xiancheng; Huang, Jennifer J; Portuguese, Andrew J; Basom, Ryan; Torkelson, Aiko; Kirchmeier, Delaney; Braathen, Kristina; Cowan, Andrew J; Shadman, Mazyar; Hirayama, Alexandre V; Till, Brian G; Kimble, Erik L; Wu, Qian; Gauthier, Jordan

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up

一项针对复发/难治性多发性骨髓瘤的全人源BCMA CAR-T疗法的I期临床试验,随访时间为5年。

Tuazon, Sherilyn A; Portuguese, Andrew J; Pont, Margot J; Cowan, Andrew J; Cole, Gabriel O; Sather, Blythe D; Song, Xiaoling; Thomas, Sushma; Wood, Brent L; Blake, Michelle; Works, Melissa G; Shadman, Mazyar; Liang, Emily C; Wu, Qian V; Voutsinas, Jenna M; Gooley, Ted A; Turtle, Cameron J; Till, Brian G; Coffey, David G; Maloney, David G; Riddell, Stanley R; Green, Damian J

Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up

真实世界中 lisocabtagene maraleucel 和 axicabtagene ciloleucel 在大 B 细胞淋巴瘤中的比较:一项为期 3 年的逆概率加权分析

Portuguese, Andrew J; Huang, Jennifer J; Jeon, Yein; Taheri, Mahnoosh; Albittar, Aya; Liang, Emily C; Hirayama, Alexandre V; Kimble, Erik L; Iovino, Lorenzo; Poh, Christina; Gopal, Ajay K; Shadman, Mazyar; Till, Brian G; Milano, Filippo; Chapuis, Aude G; Otegbeye, Folashade; Cassaday, Ryan D; Basom, Ryan S; Wu, Qian Vicky; Maloney, David G; Gauthier, Jordan

Development and validation of predictive models of early immune effector cell-associated hematotoxicity

早期免疫效应细胞相关血液毒性预测模型的建立与验证

Liang, Emily C; Huang, Jennifer J; Portuguese, Andrew J; Ortiz-Maldonado, Valentín; Albittar, Aya; Wuliji, Natalie; Basom, Ryan; Jeon, Yein; Wu, Qian; Torkelson, Aiko; Kirchmeier, Delaney; Chutnik, Abigail; Pender, Barbara; Sorror, Mohamed; Hill, Joshua A; Kopmar, Noam E; Banerjee, Rahul; Cowan, Andrew J; Green, Damian; Gopal, Ajay K; Poh, Christina; Shadman, Mazyar; Hirayama, Alexandre V; Till, Brian G; Kimble, Erik L; Iovino, Lorenzo; Chapuis, Aude G; Otegbeye, Folashade; Cassaday, Ryan D; Milano, Filippo; Turtle, Cameron J; Maloney, David G; Gauthier, Jordan

Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas

普拉曲沙对细胞毒性皮肤T细胞淋巴瘤有效。

Poh, Christina; Voutsinas, Jenna M; Shadman, Mazyar; Lynch, Ryan C; Warren, Edus H; Crimp, Caitlin A; Till, Brian G; Ujjani, Chaitra S; Di, Mengyang; Raghunathan, Vikram; Smith, Stephen D; Wu, Qian V; Shinohara, Michi M; Gopal, Ajay K

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

一项随机研究比较了苯达莫司汀-利妥昔单抗±硼替佐米诱导治疗和利妥昔单抗±来那度胺维持治疗套细胞淋巴瘤(MCL)的疗效。

Smith, Mitchell R; Jegede, Opeyemi A; Martin, Peter; Till, Brian G; Parekh, Samir S; Yang, David T; Hsi, Eric D; Witzig, Thomas; Dave, Sandeep; Scott, David; Hanson, Curtis; Kostakoglu Shields, Lale; Abdel-Samad, Nizar; Casulo, Carla; Bartlett, Nancy L; Caimi, Paolo F; Al Baghdadi, Tareq; Blum, Kristie A; Romer, Mark D; Inwards, David J; Lerner, Rachel E; Wagner, Lynne I; Little, Richard F; Friedberg, Jonathan W; Leonard, John P; Kahl, Brad S

HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation

HA-1靶向T细胞受体T细胞疗法治疗造血干细胞移植后复发性白血病

Krakow, Elizabeth F; Brault, Michelle; Summers, Corinne; Cunningham, Tanya M; Biernacki, Melinda A; Black, R Graeme; Woodward, Kyle B; Vartanian, Nicole; Kanaan, Sami B; Yeh, Albert C; Dossa, Robson G; Bar, Merav; Cassaday, Ryan D; Dahlberg, Ann; Till, Brian G; Denker, Andrew E; Yeung, Cecilia C S; Gooley, Ted A; Maloney, David G; Riddell, Stanley R; Greenberg, Philip D; Chapuis, Aude G; Newell, Evan W; Furlan, Scott N; Bleakley, Marie

Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy

CD20靶向嵌合抗原受体过继性T细胞疗法后的长期缓解

Mo, George; Lee, Sang Y; Coffey, David G; Voillet, Valentin; Kirsch, Ilan R; Gottardo, Raphael; Smythe, Kimberly S; Yeung, Cecilia C S; Greenbaum, Adam; Green, Damian J; Maloney, David G; Till, Brian G

Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic

在诊所回答“医生,CAR-T疗法会导致癌症吗?”这个问题

Banerjee, Rahul; Poh, Christina; Hirayama, Alexandre V; Gauthier, Jordan; Cassaday, Ryan D; Shadman, Mazyar; Cowan, Andrew J; Till, Brian G; Green, Damian J; Kiem, Hans-Peter; Gopal, Ajay K; Maloney, David G

Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

抗PD-L1抗体启动治疗的时机影响CD19 CAR T细胞疗法治疗大B细胞淋巴瘤的疗效/毒性。

Hirayama, Alexandre V; Kimble, Erik L; Wright, Jocelyn H; Fiorenza, Salvatore; Gauthier, Jordan; Voutsinas, Jenna M; Wu, Qian; Yeung, Cecilia C S; Gazeau, Nicolas; Pender, Barbara S; Kirchmeier, Delaney R; Torkelson, Aiko; Chutnik, Abigail N; Cassaday, Ryan D; Chapuis, Aude G; Green, Damian J; Kiem, Hans-Peter; Milano, Filippo; Shadman, Mazyar; Till, Brian G; Riddell, Stanley R; Maloney, David G; Turtle, Cameron J